Abstract
Trichomonas vaginalis (T. vaginalis) infection is one of the most common sexually transmitted infections worldwide and is associated with several complications. However, the paucity of research regarding the prevalence of T. vaginalis infection in the Tibetan area limits control efforts. We aimed to evaluate the prevalence of T. vaginalis infection in the Tibetan area by a comparison with the prevalence of T. vaginalis in Wuhan city and to unveil the potential risk factors in the Tibetan area. This descriptive, cross-sectional study was conducted among adult women attending gynecology outpatient clinics in two public hospitals (one in Shannan city of Tibet and one in Wuhan city) in China in 2020. Data were retrieved from the medical record system and laboratory information management system, including T. vaginalis infection, bacterial vaginosis, and vulvovaginal candidiasis by wet mount microscopy or nucleic acid hybridization of vaginal secretions from patients. The associations of variables associated with T. vaginalis prevalence were quantified by odds ratios with 95% confidence intervals. The overall prevalence rates of T. vaginalis infection in the Tibetan area and Wuhan city were 20.94% and 2.84%, respectively. The statistically significant factors for the higher prevalence of T. vaginalis infection in the Tibetan area included tertiary educational status (AOR: 0.36 [95% CI: 0.16–0.81]), yearly family income > ¥100,000 (AOR: 0.48 [95% CI: 0.26–0.91]), clinical symptoms (AOR: 4.58[95% CI: 2.32–9.04]), and III–IV grade vaginal cleanliness (AOR: 29.71 [95% CI: 3.95–223.56]) in the multivariate logistic analysis. Interventions targeting improved living standards as well as women’s educational level and promoting reproductive hygiene habits are recommended to contribute to the reduction in T. vaginalis infection in the Tibetan area.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Trichomonas vaginalis (T. vaginalis) infection, caused by a flagellated protozoan, is responsible for the most common curable sexually transmitted infection (STI) worldwide (Margarita et al. 2019; Workowski and Bolan 2015). T. vaginalis is recognized as one of the causative agents of infectious vaginitis (Schwebke and Burgess 2004), affecting an estimated 244.90 million cases in 195 countries (Collaborators 2018). Although up to 50% of female infections are completely asymptomatic, untreated T. vaginalis infection is well-established risk factor for vaginitis, cervicitis, pelvic inflammatory diseases, adverse outcomes of pregnancy, increased susceptibility to human papillomavirus (HPV) infections and cervical cancers, and even acquisition and transmission of human immunodeficiency virus (HIV) (Belfort et al. 2021; Blair et al. 2011; Bouchemal et al. 2017).
The prevalence estimates of T. vaginalis infection vary among different demographic groups and geographical regions. According to World Health Organization (WHO n.d.) reports, the global T. vaginalis infection rate was 5.30% in women, with the highest value of 11.70% in the African region and the lowest value of 1.60% in the European region (Rowley et al. 2019). In China, although there are no nationwide data on T. vaginalis prevalence, previous cross-sectional studies documented prevalence rates of 3.20%, 0.38%, 1.64%, and 7.44% in the southeastern (Fujian Province) (Chen et al. 2006), southern (Guangxi Province) (Lu et al. 2022), central (Henan Province) (Zhang et al. 2018), and northeastern (Jilin Province) (Li et al. 2008) areas of China, respectively. However, in clinical practice, we noticed that the prevalence of T. vaginalis infection appears to be higher in the Tibetan area than that reported by many regional population-based surveys in China (Chen et al. 2006; Dai et al. 2010; Fang et al. 2007; Li et al. 2008; Lu et al. 2022; Zhang et al. 2018). The situation creates public interests and health concerns in the area.
However, until now, relevant information for the high prevalence of T. vaginalis infection in the Tibetan area has remained sparse. Here, we conducted a cross-sectional study to highlight the difference in T. vaginalis prevalence between the Tibetan area and Wuhan city and then further analyzed potential associations between T. vaginalis prevalence and socioeconomic, behavioral, clinical, and microecological factors among the female population in the Tibetan area.
Method
Subjects
An institutional-based, comparative cross-sectional survey was conducted to evaluate the prevalence of T. vaginalis infection among women treated in two hospitals, the Maternal and Child Health Hospital of Shannan city and Wuhan Union Hospital, with different geographical backgrounds. Shannan city (29°24′N, 91°77′E) of the Tibet Autonomous Region, located in northwest China, is approximately 3000 km from Wuhan city (30°60′N, 114°27′E) which is a provincial capital city in central China (Fig. 1). Survey data were obtained from clinical visits, outpatient medical record systems, and laboratory information management systems of the hospital in the Tibetan area (June 1 to October 15, 2020) and the hospital in Wuhan city (December 1 to December 30, 2020).
Women (aged 15 years and older) with reported sexual activity, who came to the gynecology and obstetrics outpatient clinic of the above hospitals, were included in the analyses during the data collection time, regardless of the reason for vaginal secretion examination that day. Subjects were excluded if they (1) had other serious complications, (2) had taken antibiotics, or (3) underwent vaginal treatments within 2 weeks prior to the visit. Data were provided to us from the institution after removing all subject identifiers.
Ethics approval for this study was obtained from the Ethics Committee of Wuhan Union Hospital and the Maternal and Child Health Hospital of Shannan city. Written informed consents were waived in view of the retrospective nature of the study. Informed oral consent was requested from the patients by institutional review board of the Maternal and Child Health Hospital of Shannan city.
Data collection and diagnostic criteria
In Wuhan city, medical information (Spreadsheet 1) was extracted from medical chart records. Data in the Tibetan area (Spreadsheet 2) were originally abstracted through (voluntary) questionnaires as well as the outpatient medical record including socioeconomic factors (age, ethnic group, education, occupation, yearly family income, and marital status) and clinical and behavioral information (current pregnancy, gravidity, frequency of sex and contraception within the past 6 months, bath, frequency of vulva cleaning, smoking and alcohol habits, and symptoms). Women who had unusual vaginal discharge, itching, odor, irritations, or pelvic pain in the past week were included in the positive symptom group. The age and yearly family income groups were divided according to the median. Then, data related to the condition of the vulva, vagina, secretions, and cervix from gynecological examination records were collected and combined with other data.
Laboratory-based data relied on vaginal exudate samples collected by a sterile vaginal swab from the posterior fornix and the vaginal wall after examinations of the vagina and cervix with a speculum. In the Tibetan area, saline drops with the vaginal sample were smeared immediately on a clean glass slide with a cover slip and then examined microscopically at a magnification of × 40 for motile pear-shaped trophozoites within 10 min. This slide was also examined microscopically for vaginal cleanliness, clue cells, and hyphae or spores by qualified laboratory personnel. Then, the second vaginal swab was heat-fixed, gram-strained, and examined under a 100 × oil immersion objective for the diagnosis of bacterial vaginosis (BV) (Nugent et al. 1991). This slide was also observed under an oil immersion field microscope for the presence of mycelia or pseudohyphae. In Wuhan city, nucleic acid hybridization (Dessai et al. 2020) was performed by placing vaginal swabs into sterile sampling containers with Stuart’s medium and transporting them to the laboratory for detecting microbiological species.
For wet mount microscopy, positive vulvovaginal candidiasis (VVC) results were diagnosed microscopically by the presence of mycelia or pseudohyphae. A positive T. vaginalis result was determined by identification of pear-shaped and motile organisms with flagella and undulating membranes (Schwebke and Burgess 2004). A clinical positive diagnosis of BV was defined as a Nugent score of 7–10 (Nugent et al. 1991) or the presence of three out of four Amsel’s criteria (Amsel et al. 1983): homogenous vaginal discharge, pH > 4.5, clue cells > 20% on saline microscopy, and a positive “whiff test” result (a fishy odor on addition of 10% KOH to vaginal fluid). For nucleic acid hybridization, clinically significant amounts of DNA of T. vaginalis (5 × 103 cells/ml), Gardnerella (2 × 105 CFU/ml), and Candida species (1 × 104 CFU/ml) were treated as positive results by the BD Affirm VPIII Microbial Identification Test Kit (Becton, Dickinson and Company, USA).
Statistical analysis
All related data are summarized in Supplementary Spreadsheets and were analyzed using SPSS software (version 26). The independent t test or chi-square tests were used for continuous and categorical variables, respectively, to estimate statistical comparisons between two groups. To identify significant differences in subgroups of Tibetan data, the chi-square test or Fisher’s exact test was used in univariate analysis. A logistic regression model was performed in multivariate analysis including only P < 0.05 variables in univariate analysis. Figures were created and arranged using GraphPad Prism (version 8) and Adobe Illustrator 2022. P < 0.05 was considered statistically significant.
Results
Baseline patient characteristics
A total of 406 patients in the Tibetan area and 529 patients in Wuhan city were included in this study. Of the 529 patients in Wuhan, average age was 36.57 years (range 15 to 83 years), 96.03% were married or living with partner, and none were ethnic Tibetan. In the Tibetan area, the study sample consisted of 406 patients with mean ages of 34 years (range from 18 to 68 years), the majority of whom were Tibetan (89.90%), married (94.09%), and had a yearly family income ≤ 100,000 yuan (59.36%). Approximately one-third (31.28%) reported a primary or below education, and nearly four in ten (40.89%) were unemployed (farmers or herdsmen). Demographics of the patients are presented in Tables 1 and 2.
Prevalence of vaginitis in two regions
There was a higher prevalence of T. vaginalis infection but a lower prevalence of BV or VVC in the Tibetan area (all P < 0.01). As depicted in Table 1, statistically significant differences (P < 0.01) were detected in age and ethnic groups between the two regions, except for marital status (P > 0.05).
In Wuhan city, the most common vaginal infection was BV (41.97%), 25.33% women had VVC, 2.84% T. vaginalis (Table 1). T. vaginalis infection was the most common vaginal infection of the three in the Tibetan area (20.94%), following by BV (17.00%) and VVC (6.40%) (Fig. 2). On further analyses, we found a significant difference between the prevalence of T. vaginalis and VVC (P < 0.05), but there were no significant differences between BV and T. vaginalis or VVC (P > 0.05). At least one infection (BV, VVC or T. vaginalis infection) was found in 39.41% (160/406) of the women. The rate of coinfection was 4.93% (20/406): 17 subjects (4.19%) were coinfected with T. vaginalis and BV, and 3 subjects (0.74%) were coinfected with BV and VVC.
Factors that influence T. vaginalis infection in Tibetan patients
Table 2 shows that the T. vaginalis prevalence varied among the subgroups. Women equal to or less than 35 years old had a somewhat higher prevalence (24.30%) of T. vaginalis infection (P < 0.05). Prevalence rates of 8.4% and 10.8% were observed in women with tertiary (college or higher) education and family income > 100,000 yuan/year, respectively; the rates increased when stratified women had less education or lower family income (P < 0.01).
Regardless of behavioral characteristics, comparatively lower rates of T. vaginalis infection occurred in women using condoms during sex (13.40%, P < 0.05) and in women who had no sex recently (3.85%, P < 0.05). There were significant findings linking T. vaginalis prevalence and the frequency of vulva cleaning (P < 0.05). Patients who bathed their vulva region more often than once a week were less likely to be T. vaginalis positive than those who did not (18.46% vs. 30.86%, P < 0.05). Similarly, the odds of T. vaginalis infection were lower in subjects with normal vaginal cleanliness grade I-II than in subjects with grade III-IV (1.01% vs. 27.36%, P < 0.05).
The individual symptoms, such as itching, abnormal odor, vaginal discharge, abdominal pain, and frequent urination, were associated with T. vaginalis infections. Only 7.11% of the asymptomatic women were positive for T. vaginalis, which was significantly lower than 33.97% in symptomatic group (P < 0.01). None of the women who currently have VVC was infected with T. vaginalis. Being diagnosed positive for VVC was strongly associated with T. vaginalis (P < 0.01), while BV was not (P > 0.05).
Based on the multivariate adjustment (Table 2), women who reported clinical symptoms were more than four times as likely to acquire T. vaginalis infections (OR = 4.58, 95% CI: 2.32–9.04, P < 0.01). III–IV vaginal cleanliness was also identified as an independent risk factor for T. vaginalis infections (OR = 29.71, 95% CI: 3.95–223.56, P < 0.01). Tertiary education (OR = 0.36, 95% CI: 0.16–0.81, P < 0.01) and yearly family income > 100,000 yuan (OR = 0.48, 95% CI: 0.26–0.91, P < 0.05) were protective factors against being T. vaginalis positive.
Discussion
Although T. vaginalis has been confirmed to be linked to a range of adverse gynecological and obstetric outcomes, little emphasis has been placed on detecting its prevalence and risk factors in the recent past, such that there is no overall prevalence rate in China. This population-based study is the first to compare the prevalence rate of T. vaginalis in two hospitals located in different geographical regions (central vs. western China). A relatively high rate (20.94%) of T. vaginalis-infected females were identified in the Tibetan area compared with those (2.84%) obtained in Wuhan city. The prevalence rate of T. vaginalis in Wuhan city, a city with relatively richer medical resources in central China, is close to the reported rates from other regions (range from 0.4 to 7.4%) in China. This study focused on the possible risk factors in the female population in the Tibetan area. Among this population, risk factors related to T. vaginalis infection include lower educational status and family income, clinical symptoms, and a high level of vaginal cleanliness.
T. vaginalis was present in 20.94% of these Tibetan patients, which was obviously higher than that in the WHO regions (range from 1.60 to 11.70%) (Rowley et al. 2019) and in other reported provinces of China (Guangxi, 0.38%; Henan, 1.64%; Sichuan, 2.52%; Shandong, 2.80%; Fujian, 3.17%; Jilin, 7.44%) (Chen et al. 2006; Dai et al. 2010; Fang et al. 2007; Li et al. 2008; Lu et al. 2022; Zhang et al. 2018). It is a comparable rate of T. vaginalis to that previously reported among HIV-positive pregnant women (20.14%) in South Africa (Peters et al. 2021). However, in South Africa, a systematic review including 48 studies from 2015 to 2020 reported a pooled prevalence of 13.8% among pregnant women (Nyemba et al. 2021). This illustrates that the prevalence of T. vaginalis varies based on population characteristics. Although the disparity between the two regions presented above might be due to differences in the target population, this result indicated the widespread existence of T. vaginalis infection in the Tibetan area. Although wet-mount microscopy showed a poorer sensitivity (Ghallab et al. 2021) for detecting T. vaginalis in the Tibetan area than nucleic acid hybridization, which was used in Wuhan city, the result was unexpected. Given the low sensitivity of wet-mount microscopy, it is likely that the actual prevalence rate of T. vaginalis may be higher than that in the present study. Thus, identifying socioeconomic status and behavior and lifestyle factors rather than the population specificity of selected Tibetan women might be crucial to explain the T. vaginalis prevalence.
Furthermore, it is well established that T. vaginalis infection is a sexually transmitted infection (Workowski and Bolan 2015). Inadequate treatment and lack of concurrent treatment of sexual partners may be related to the continuing epidemics of T. vaginalis infection (Schumann and Plasner 2022). As our findings shows, the prevalence of T. vaginalis infection was highest in the Tibetan area, followed by BV and VVC. This result was inconsistent with some previous reports including another Tibetan area in China and a resource-limited region in India, both of which showed that T. vaginalis was less common than BV or VVC (Dai et al. 2010; Khan et al. 2019). Lack of formal treatment for T. vaginalis infection seems to be a reason for the disparity, leading to a high prevalence.
In this study, women with educational levels lower than college were more likely to have a T. vaginalis infection, which is consistent with early findings from the USA and Nigeria (Aboyeji and Nwabuisi 2003; Rosenbaum 2018; Tompkins et al. 2020). As a result of lower education, women may lack knowledge of T. vaginalis or other sexually transmitted diseases; thus, they may be unaware of the importance of correct, habitual, and consistent use of condoms. Among the highly educated women in the current study, nearly half (46.34%) reported condom use with regular partners; in contrast, a low rate of condom use (11.30%) was shown in the primary or below education subgroup. Another potential reason for this issue is that low-educated women do not realize the need to seek medical attention upon experiencing symptoms of T. vaginalis due to limited knowledge about the disease. Such conditions might increase the spread of T. vaginalis. Thus, further efforts to improve educational levels are needed to prevent T. vaginalis infection in the Tibetan area.
Family income was strongly associated with the likelihood of T. vaginalis infection in our study. Cases were more prevalent among females with family income below the average level, which is the same as prior reports in the USA and southern Brazil (Gatti et al. 2017; Patel et al. 2018). In accordance with the WHO, women in low-income countries undertake a greater burden of T. vaginalis infection (Organization. 22 August 2022). For one, lower income in many cases means lower educational attainment, the evidence of which was a smaller proportion (15.40%) of women with lower income received a college education compared to women with higher family income. Another reason for this is poor access to health care in low-income women, which leads to a higher risk of transmission of T. vaginalis. Thus, more interventions for improving living standards should be targeted to this population.
Using a condom for sex was a protective factor against T. vaginalis infection, as reported by Barbosa et al. (2020). In this study, women who did not use condoms for sex were twice as likely to be T. vaginalis positive than women who did. Speculatively, we would suggest that the marked disparity might be partly due to continued transmission from asymptomatic sex partners. Without awareness of infection, asymptomatic sex partners readily transmit T. vaginalis to women during penile-vaginal sexual encounters. Additionally, women who reported no sex in the past six months were less likely to be infected with T. vaginalis, which is closely linked to a reduction in the likelihood of transmission via sexual contact. These results highlight that consistent and correct condom use can prevent the transmission of T. vaginalis by providing an effective barrier against pathogens (Wan Muda et al. 2018).
The proportion of asymptomatic carriers of T. vaginalis should not be overlooked. Our study found that only 14 of the 85 (16.47%) T. vaginalis-positive women were asymptomatic, compared with nearly 80%, a universally recognized level (Workowski and Bolan 2015). A greater percentage of T. vaginalis-positive women came to this hospital because they had related uncomfortable symptoms. This is problematic since some women in this area are unaware of the importance of having regular gynecological examinations unless symptoms appear. Hence, general surveillance for sexually transmitted diseases, an effective way to prevent T. vaginalis infection, is needed.
The major strength of this study was the high rate of testing T. vaginalis infection and a real-life condition in the process of diagnosis in the hospital. Moreover, the characteristics of the population enrolled in this study have rarely been studied before. The limitations of the study were as follows. This study recruited only participants with associated symptoms or those who just came for medical attention in the hospital; thus, the limit affected the generalizability and led to selection bias. For measurement bias, our subsequent studies should introduce more sensitive tests and biochemical indicators based on direct microscopy to improve the sensitivity.
On the basis of this study, we conclude that the prevalence of T. vaginalis infection is estimated to be 20.94% among women treated in the hospital of Shannan city during this period. Associated risk factors included lower educational status and family income, higher sexual frequency, nonuse of condoms, clinical symptoms, and a high level of vaginal cleanliness. Our results have improved our understanding of the prevention of T. vaginalis in the Tibetan area. To effectively reduce the occurrence of T. vaginalis infection in this area, adopted measures depended on different customs and demographic characteristics, including raising the standard of living as well as women’s educational level and promoting reproductive hygiene habits.
Data availability
All relevant data are within the paper.
References
Aboyeji AP, Nwabuisi C (2003) Prevalence of sexually transmitted diseases among pregnant women in Ilorin, Nigeria. J Obstet Gynaecol 23:637–639. https://doi.org/10.1080/01443610310001604411
Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14–22. https://doi.org/10.1016/0002-9343(83)91112-9
Barbosa MdS, de Souza IBA, dos Santos Schnaufer EC, da Silva LF, Goncalves CCM, Simionatto S, Marchioro SB (2020) Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women. PLoS ONE 15:e0240323. https://doi.org/10.1371/journal.pone.0240323
Belfort IKP, Cunha APA, Mendes FPB et al (2021) Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil. BMC Womens Health 21:174. https://doi.org/10.1186/s12905-021-01320-6
Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD (2011) Clinical and behavioral characteristics of adults receiving medical care for HIV infection –- Medical Monitoring Project, United States, 2007. MMWR Surveill Summ 60:1–18
Bouchemal K, Bories C, Loiseau PM (2017) Strategies for prevention and treatment of Trichomonas vaginalis Infections. Clin Microbiol Rev 30:811–825. https://doi.org/10.1128/CMR.00109-16
Chen XS, Yin YP, Chen LP et al (2006) Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, China. Sex Transm Dis 33:296–301. https://doi.org/10.1097/01.olq.0000194580.02116.6b
Dai Q, Hu L, Jiang Y et al (2010) An epidemiological survey of bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis in the Tibetan area of Sichuan Province, China. Eur J Obstet Gynecol Reprod Biol 150:207–209. https://doi.org/10.1016/j.ejogrb.2010.02.027
Dessai F, Nyirenda M, Sebitloane M, Abbai N (2020) Diagnostic evaluation of the BD Affirm VPIII assay as a point-of-care test for the diagnosis of bacterial vaginosis, trichomoniasis and candidiasis. Int J STD AIDS 31:303–311. https://doi.org/10.1177/0956462419895684
Fang X, Zhou Y, Yang Y, Diao Y, Li H (2007) Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis 60:257–261
Gatti FA, Ceolan E, Greco FS et al (2017) The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil. PLoS ONE 12:e0173604. https://doi.org/10.1371/journal.pone.0173604
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1789–1858.https://doi.org/10.1016/S0140-6736(18)32279-7
Ghallab MMI, Alaa D, Morsy SM (2021) Multiattribute analysis of Trichomonas vaginalis diagnostics and its correlation with clinical complaints and contraceptive methods in a symptomatic Egyptian cohort. Infect Dis Obstet Gynecol 2021:5525095. https://doi.org/10.1155/2021/5525095
Khan Z, Bhargava A, Mittal P, Bharti R, Puri P, Khunger N, Bala M (2019) Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India. BMJ Open 9:e025013. https://doi.org/10.1136/bmjopen-2018-025013
Li S, Jiang Z, Huo W, Fan J, Cui L, Han S (2008) The prevalence of trichomonas vaginalis among patients in department of gynecology. Maternal and Child Health Care of China 23:1262–1263. https://doi.org/10.3969/j.issn.1001-4411.2008.09.048
Lu H, He H, He X et al (2022) Prevalence and spatial heterogeneity of Trichomonas vaginalis infection among the female population and association with climate in Guangxi Zhuang autonomous region, Southern China. Acta Trop 225:106204. https://doi.org/10.1016/j.actatropica.2021.106204
Margarita V, Marongiu A, Diaz N, Dessi D, Fiori PL, Rappelli P (2019) Prevalence of double-stranded RNA virus in Trichomonas vaginalis isolated in Italy and association with the symbiont Mycoplasma hominis. Parasitol Res 118:3565–3570. https://doi.org/10.1007/s00436-019-06469-6
Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301. https://doi.org/10.1128/jcm.29.2.297-301.1991
Nyemba DC, Haddison EC, Wang C, Johnson LF, Myer L, Davey DJ (2021) Prevalence of curable STIs and bacterial vaginosis during pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect. https://doi.org/10.1136/sextrans-2021-055057
Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AAR (2018) Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis 67:211–217. https://doi.org/10.1093/cid/ciy079
Peters R, Klausner JD, de Vos L, Feucht UD, Medina-Marino A (2021) Aetiological testing compared with syndromic management for sexually transmitted infections in HIV-infected pregnant women in South Africa: a non-randomised prospective cohort study. BJOG 128:1335–1342. https://doi.org/10.1111/1471-0528.16617
Rosenbaum JE (2018) Graduating into lower risk: chlamydia and Trichomonas prevalence among community college students and graduates. J Health Dispar Res Pract 11:104–121
Rowley J, Vander Hoorn S, Korenromp E et al (2019) Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 97:548-562P. https://doi.org/10.2471/BLT.18.228486
Schumann JA, Plasner S (2022) Trichomoniasis. StatPearls Publishing, StatPearls, Treasure Island (FL)
Schwebke JR, Burgess D (2004) Trichomoniasis. Clin Microbiol Rev 17:794–803, table of contents. https://doi.org/10.1128/CMR.17.4.794-803.2004
Tompkins EL, Beltran TA, Gelner EJ, Farmer AR (2020) Prevalence and risk factors for Trichomonas vaginalis infection among adults in the U.S., 2013–2014. PLoS One 15:e0234704. https://doi.org/10.1371/journal.pone.0234704
Wan Muda WM, Wong LP, Tay ST (2018) Prevention practices of vaginitis among Malaysian women and its associated factors. J Obstet Gynaecol 38:708–715. https://doi.org/10.1080/01443615.2017.1405923
Workowski KA, Bolan GA (2015) Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and reports : morbidity and mortality weekly report 64(RR-03):1–137
World Health Organization (n.d.) Sexually transmitted infections (STIs). Geneva, Switzerland: World Health Organization. http://www.who.int/mediacentre/factsheets/fs110/en/. Accessed 22 Aug 2022
Yu F, Tang YT, Hu ZQ, Lin XN (2018) Analysis of the vaginal microecological status and genital tract infection characteristics of 751 pregnant women. Med Sci Monit 24:5338–5345. https://doi.org/10.12659/MSM.909051
Zhang Z, Kang L, Wang W et al (2018) Prevalence and genetic diversity of Trichomonas vaginalis clinical isolates in a targeted population in Xinxiang City, Henan Province, China. Parasit Vectors 11:124. https://doi.org/10.1186/s13071-018-2753-4
Acknowledgements
We are thankful to the gynecological staff of Maternal and Child Health Hospital of Shannan city for their support throughout the sample collection. Also, we appreciate the support of the Department of Gynecology of Wuhan Union Hospital for giving us an opportunity to aid Tibet so that we can realize the prevalence of vaginitis in the Tibetan area.
Author information
Authors and Affiliations
Contributions
Xiaowu Zhu and Linlin Liu conceived and designed the study, visualized data and wrote the manuscript. Lamu Yixi, Yanan Yang, Yan Zhang, and Yang Zhen contributed equally the data: they abstracted and prepared the data. Jinfeng Dong checked the data, and then Huali Chen interpreted. Shouhua Yang participated in study conception and supervision and provided edits. All authors approved the final version.
Corresponding author
Ethics declarations
Ethics approval
This research study was conducted retrospectively from data obtained for clinical purposes. Ethics approval for this study was obtained from the Ethics Committee of Wuhan Union Hospital (approval number: UHCT-IEC-SOP-016–03-01) and was waived by the Ethics Committee of the Maternal and Child Health Hospital of Shannan city in view of the retrospective nature of the study. All procedures were performed according to the ethical standards of Helsinki Declaration.
Consent to participate
Informed consent requirements were waived from this retrospective study by Ethics Committee, but participating clinicians still provided informed consent for participants in clinical practice.
Consent to publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Section Editor: Yaoyu Feng
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhu, X., Liu, L., Yixi, L. et al. The prevalence and risk factors of Trichomonas vaginalis in Wuhan and the Tibetan area, China: a two-center study. Parasitol Res 122, 265–273 (2023). https://doi.org/10.1007/s00436-022-07726-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-022-07726-x